All Stories

  1. Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2018, Dove Medical Press

    Professor Masaharu Nishimura, Yihua Zhao

  2. Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2018, Dove Medical Press

    Professor Masaharu Nishimura, Yihua Zhao

  3. Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2017, Dove Medical Press

    Professor Chunxue Bai, Professor Sang Haak Lee, Yihua Zhao

  4. The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2016, Dove Medical Press

    Professor Yoshinosuke Fukuchi, Yihua Zhao, Dr. Florian Voß